[Agranulocytosis during a treatment by the chloroacetylajmaline].
D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced*; D000404:Ajmaline / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans
D000404:Ajmaline
Agranulocytose au cours d'un traitement par la chloroacétylamjmaline.